News | July 26, 2022
GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
With this, the company can start selling Ibuprofen in the European markets.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
Subscribe To Our Newsletter & Stay Updated
